Marker Therapeutics

Marker Therapeutics is committed to the development and commercialization of next-generation T cell-based immunotherapies for patients with various hematologic and solid tumors. Our team consists of talented and passionate professionals with deep expertise in cancer immunotherapy and a strong desire to provide effective treatments for patients who currently have little or no therapeutic options.